Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.

Renz BW, Thasler WE, Preissler G, Heide T, Khalil PN, Mikhailov M, Jauch KW, Kreis ME, Rentsch M, Kleespies A.

J Gastrointest Surg. 2013 May;17(5):981-90. doi: 10.1007/s11605-013-2171-z. Epub 2013 Mar 9.

PMID:
23475629
2.

A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome.

Hrabe JE, Byrn JC, Button AM, Zamba GK, Kapadia MR, Mezhir JJ.

J Surg Oncol. 2014 Feb;109(2):117-21. doi: 10.1002/jso.23465. Epub 2013 Oct 16.

PMID:
24132737
3.

Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.

Adams SV, Ahnen DJ, Baron JA, Campbell PT, Gallinger S, Grady WM, LeMarchand L, Lindor NM, Potter JD, Newcomb PA.

World J Gastroenterol. 2013 Jun 7;19(21):3241-8. doi: 10.3748/wjg.v19.i21.3241.

4.

Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study.

Thicoïpé A, Laharie D, Smith D, Chabrun E, Rullier A, Poullenot F, Rullier E, Denost Q.

Int J Colorectal Dis. 2018 Jul;33(7):963-966. doi: 10.1007/s00384-018-3049-z. Epub 2018 Apr 19.

PMID:
29675590
5.

Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.

Ali RA, Dooley C, Comber H, Newell J, Egan LJ.

Clin Gastroenterol Hepatol. 2011 Jul;9(7):584-9.e1-2. doi: 10.1016/j.cgh.2011.04.016. Epub 2011 Apr 22.

PMID:
21565283
6.

Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).

Peyrin-Biroulet L, Lepage C, Jooste V, Guéant JL, Faivre J, Bouvier AM.

Inflamm Bowel Dis. 2012 Dec;18(12):2247-51. doi: 10.1002/ibd.22935. Epub 2012 Mar 29.

PMID:
22467511
7.

Increased incidence of prolonged ileus after colectomy for inflammatory bowel diseases under ERAS protocol: a cohort analysis.

Dai X, Ge X, Yang J, Zhang T, Xie T, Gao W, Gong J, Zhu W.

J Surg Res. 2017 May 15;212:86-93. doi: 10.1016/j.jss.2016.12.031. Epub 2016 Dec 29.

PMID:
28550927
8.

A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.

Reynolds IS, O'Toole A, Deasy J, McNamara DA, Burke JP.

Int J Colorectal Dis. 2017 Apr;32(4):443-451. doi: 10.1007/s00384-017-2754-3. Epub 2017 Jan 11. Review.

PMID:
28078433
9.

Factors affecting surgical risk in elderly patients with inflammatory bowel disease.

Page MJ, Poritz LS, Kunselman SJ, Koltun WA.

J Gastrointest Surg. 2002 Jul-Aug;6(4):606-13.

PMID:
12127128
10.

Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits.

Chang BW, Kumar AM, Koyfman SA, Kalady M, Lavery I, Abdel-Wahab M.

Int J Colorectal Dis. 2015 Mar;30(3):403-8. doi: 10.1007/s00384-014-2103-8. Epub 2015 Jan 8.

PMID:
25564345
11.

Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.

Kiran RP, Khoury W, Church JM, Lavery IC, Fazio VW, Remzi FH.

Ann Surg. 2010 Aug;252(2):330-5. doi: 10.1097/SLA.0b013e3181e61e69.

PMID:
20622662
12.

Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.

Axelrad J, Kriplani A, Ozbek U, Harpaz N, Colombel JF, Itzkowitz S, Holcombe RF, Ang C.

Clin Colorectal Cancer. 2017 Sep;16(3):e205-e210. doi: 10.1016/j.clcc.2016.09.005. Epub 2016 Sep 20.

13.

Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study.

Gearhart SL, Nathan H, Pawlik TM, Wick E, Efron J, Shore AD.

Dis Colon Rectum. 2012 Mar;55(3):270-7. doi: 10.1097/DCR.0b013e318242620f.

PMID:
22469793
14.

Long-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients: A Large Institutional-Based Retrospective Study.

Kim TJ, Kim ER, Hong SN, Chang DK, Kim YH.

Medicine (Baltimore). 2016 May;95(19):e3641. doi: 10.1097/MD.0000000000003641.

15.

Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.

Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF.

Transplantation. 2003 Jun 27;75(12):1983-8.

PMID:
12829898
16.

Anastomotic leakage is associated with poor long-term outcome in patients after curative colorectal resection for malignancy.

Law WL, Choi HK, Lee YM, Ho JW, Seto CL.

J Gastrointest Surg. 2007 Jan;11(1):8-15.

PMID:
17390180
17.

Colorectal cancer prognosis among patients with inflammatory bowel disease.

Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV Jr.

Clin Gastroenterol Hepatol. 2006 Mar;4(3):335-42.

PMID:
16527697
18.

Clinical features and prognosis in colorectal cancer patients with different ethnicities in Northwest China.

Yusup A, Wang HJ, Rahmutula A, Sayim P, Zhao ZL, Zhang GQ.

World J Gastroenterol. 2013 Nov 7;19(41):7183-8. doi: 10.3748/wjg.v19.i41.7183.

19.

Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.

Leowardi C, Schneider ML, Hinz U, Harnoss JM, Tarantino I, Lasitschka F, Ulrich A, Büchler MW, Kadmon M.

Ann Surg Oncol. 2016 Mar;23(3):870-6. doi: 10.1245/s10434-015-4915-3. Epub 2015 Oct 14.

PMID:
26467453
20.

Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.

Andreoni B, Chiappa A, Bertani E, Bellomi M, Orecchia R, Zampino M, Fazio N, Venturino M, Orsi F, Sonzogni A, Pace U, Monfardini L.

World J Surg Oncol. 2007 Jul 4;5:73.

Supplemental Content

Support Center